Form 4: IDEXX Executive Vice President Exercises Stock Options
SEC Form 4
Michael G. Erickson, Executive Vice President of IDEXX Laboratories, exercised stock options to acquire 1,544 shares of common stock at $67.85 per share.
Summary
- On February 11, 2025, Michael G. Erickson, an Executive Vice President at IDEXX Laboratories, exercised incentive stock options.
- This transaction involved the acquisition of 1,544 shares of IDEXX common stock at a price of $67.85 per share.
- Following the transaction, Erickson directly owns 20,836.3617 shares of IDEXX common stock.
- The stock options were granted previously and vested on February 14, 2021, with the option to buy 1,544 shares of Issuer common stock.
- Lily J. Lu, Attorney-in-Fact, signed the document on February 12, 2025, on behalf of Michael G. Erickson.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for maintaining investor confidence.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| February 14, 2021 | Date the stock options vested. |
| February 11, 2025 | Date of the stock option exercise transaction. |
| February 12, 2025 | Date the Form 4 was signed. |
| February 13, 2026 | Expiration date of the incentive stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.